Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells

N/ACitations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Corticotropin releasing factor (CRF) induces a rapid, within seconds, and dose-dependent increase in the intracellular Ca2+ in both human and hamster melanoma cells. This effect is inhibited by depletion of extracellular calcium using 3 mM EGTA and is attenuated by the CRF receptor antagonist, α-helical-CRF(9-41). Other peptides of the CRF superfamily, sauvagine and urocortin, also induce increases in cytoplasmic calcium concentration but at higher concentrations than CRF. We conclude that malignant melanocytes express CRF receptors, which are coupled to activation of plasma membrane calcium channels. Copyright (C) 1998 Federation of European Biochemical Societies.

Cite

CITATION STYLE

APA

Fazal, N., Slominski, A., Choudhry, M. A., Wei, E. T., & Sayeed, M. M. (1998). Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells. FEBS Letters, 435(2–3), 187–190. https://doi.org/10.1016/S0014-5793(98)01067-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free